TickerFacts.

Compare

PROCEPT BioRobotics Corp vs Angiodynamics Inc vs Tactile Systems Technology Inc vs Lemaitre Vascular Inc

Latest annual figures from SEC filings. Each company is shown for its own most recent fiscal year, so period ends can differ. Select a figure to see its full history.

Latest fiscal yearPROCEPT BioRobotics Corp
PRCT		Angiodynamics Inc
ANGO		Tactile Systems Technology Inc
TCMD		Lemaitre Vascular Inc
LMAT
Year ended2025-12-312026-05-312025-12-312025-12-31
Revenue$308.05M$320.17M$329.52M$249.60M
Revenue growth (YoY)+37.2%+9.5%+12.5%+13.5%
Gross margin63.7%54.6%75.9%71.5%
Operating margin-33.7%-12.5%8.9%27.2%
Net margin-31.0%-11.5%5.8%23.1%
Net income-$95.57M-$36.74M$19.09M$57.73M
EPS (Diluted)-$1.72-$0.88$0.82$2.52
Operating cash flow-$48.98M$3.09M$42.81M$81.25M
Free cash flow-$58.34M$508.0K$40.43M$74.47M
Cash & equivalents$286.50M$53.86M$83.45M$28.24M
Total assets$508.08M$267.16M$273.94M$615.69M
Total liabilities$142.21M$96.34M$55.04M$222.17M
Shareholders' equity$365.87M$170.82M$218.90M$393.52M
Return on year-end equity-26.1%-21.5%8.7%14.7%
Shares outstanding56.32M41.70M22.44M22.77M

n/a means the company did not report that line under the concept TickerFacts maps, not that it is zero.

Revenue, most recent five fiscal years

Fiscal yearPROCEPT BioRobotics CorpAngiodynamics IncTactile Systems Technology IncLemaitre Vascular Inc
Latest$308.05M
Ended 2025-12-31		$320.17M
Ended 2026-05-31		$329.52M
Ended 2025-12-31		$249.60M
Ended 2025-12-31
1 year earlier$224.50M
Ended 2024-12-31		$292.50M
Ended 2025-05-31		$292.98M
Ended 2024-12-31		$219.86M
Ended 2024-12-31
2 years earlier$136.19M
Ended 2023-12-31		$303.91M
Ended 2024-05-31		$274.42M
Ended 2023-12-31		$193.48M
Ended 2023-12-31
3 years earlier$75.01M
Ended 2022-12-31		$338.75M
Ended 2023-05-31		$246.78M
Ended 2022-12-31		$161.65M
Ended 2022-12-31
4 years earlier$34.47M
Ended 2021-12-31		$316.22M
Ended 2022-05-31		$208.06M
Ended 2021-12-31		$154.42M
Ended 2021-12-31